Single daily oral dose of gemfibrozil reduces postprandial hyperlipidemia in hyperlipidemic patients

Authors: Descamps O.; Hondekijn J.-C.; Godrie T.; Desager J.-P.; Heller F.R.¹

Source: Current Therapeutic Research, Volume 59, Number 8, August 1998 , pp. 545-555(11)

Publisher: Elsevier

Keywords: gemfibrozil; hyperlipidemia; postprandial hyperlipidemia; lipoprotein lipase; hepatic lipase

Language: English

Document Type: Research article

DOI: 10.1016/S0011-393X(98)85094-7

Affiliations: 1: aTumor Metabolism Study Group, Hopital de Jolimont, Haine Saint Paul, , Belgium

Links for this article

http://www.ingentaconnect.com/els/0011393x/1998/00000059/00000008/art85094
http://openurl.ingenta.com/content?genre=article&issn=0011-393X&volume=59&issue=8&spage=545&epage=555
http://dx.doi.org/10.1016/S0011-393X(98)85094-7